CD44 and cancer: Here we report the results of the first-of-its-kind genome-wide analysis of mRNA-lncRNA co-expression networks in a CD133+/CD44+ PDAC cell subpopulation isolated by the highly aggressive cancer cell lines MIA PaCa-2 and PANC-1.